Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Cadre Holdings, Inc.CDRE · Entity 4819 | CHIEF FINANCIAL OFFICER | June 16, 2026 | June 18, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Cadre Holdings, Inc.
Report date June 16, 2026 · Filed June 18, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 48,500 |
Reported balance
After 2026-06-16 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-06-16 · Grant · Acquired 48,500 · Balance 48,500 F1: Represents an award of restricted stock units granted under Cadre Holdings, Inc.'s (the "Issuer") 2021 Stock Incentive Plan (the "Plan"), consisting of 48,500 restricted stock units relating to shares of the Issuer's common stock, par value $0.0001 per share ("Common Stock"). The restricted stock units will vest only if, on or before June 16, 2033, the Common Stock achieves a volume-weighted average trading price ("VWAP") of at least $60.00 per share over a 20 consecutive trading day measurement period, with any such vesting to occur upon the later to occur of the date such VWAP condition is achieved and the third anniversary of the date of grant. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 69,500 |
Reported balance
After 2026-06-16 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-06-16 · Grant · Acquired 69,500 · Balance 69,500 F2: Represents an award of restricted stock units granted under the Plan, consisting of 69,500 restricted stock units relating to shares of the Issuer's Common Stock. The restricted stock units will vest only if, on or before June 16, 2033, the Common Stock achieves a VWAP of at least $80.00 per share over a 20 consecutive trading day measurement period, with any such vesting to occur upon the later to occur of the date such VWAP condition is achieved and the third anniversary of the date of grant. |
| Stock Option (right to purchase)SEC Table II · derivative / convertible security · Conversion / exercise price $28.75 · Expires 2033-06-16 | Direct | 92,500 |
Reported balance
After 2026-06-16 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2026-06-16 · Grant · Acquired 92,500 · Balance 92,500 F3: The option to purchase shares of the Issuer's Common Stock was granted under the Plan. Options to purchase 92,500 shares of the Issuer's Common Stock will vest and become exercisable only if, on or before June 16, 2033, the Common Stock achieves a VWAP of at least $60.00 per share over a 20 consecutive trading day measurement period, with any such vesting and exercisability to occur upon the later to occur of the date such VWAP condition is achieved and the third anniversary of the date of grant. |
| Stock Option (right to purchase)SEC Table II · derivative / convertible security · Conversion / exercise price $28.75 · Expires 2033-06-16 | Direct | 115,000 |
Reported balance
After 2026-06-16 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2026-06-16 · Grant · Acquired 115,000 · Balance 115,000 F4: The option to purchase shares of the Issuer's Common Stock was granted under the Plan. Options to purchase 115,000 shares of the Issuer's Common Stock will vest and become exercisable only if, on or before June 16, 2033, the Common Stock achieves a VWAP of at least $80.00 per share over a 20 consecutive trading day measurement period, with any such vesting and exercisability to occur upon the later to occur of the date such VWAP condition is achieved and the third anniversary of the date of grant. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents an award of restricted stock units granted under Cadre Holdings, Inc.'s (the "Issuer") 2021 Stock Incentive Plan (the "Plan"), consisting of 48,500 restricted stock units relating to shares of the Issuer's common stock, par value $0.0001 per share ("Common Stock"). The restricted stock units will vest only if, on or before June 16, 2033, the Common Stock achieves a volume-weighted average trading price ("VWAP") of at least $60.00 per share over a 20 consecutive trading day measurement period, with any such vesting to occur upon the later to occur of the date such VWAP condition is achieved and the third anniversary of the date of grant.
F2: Represents an award of restricted stock units granted under the Plan, consisting of 69,500 restricted stock units relating to shares of the Issuer's Common Stock. The restricted stock units will vest only if, on or before June 16, 2033, the Common Stock achieves a VWAP of at least $80.00 per share over a 20 consecutive trading day measurement period, with any such vesting to occur upon the later to occur of the date such VWAP condition is achieved and the third anniversary of the date of grant.
F3: The option to purchase shares of the Issuer's Common Stock was granted under the Plan. Options to purchase 92,500 shares of the Issuer's Common Stock will vest and become exercisable only if, on or before June 16, 2033, the Common Stock achieves a VWAP of at least $60.00 per share over a 20 consecutive trading day measurement period, with any such vesting and exercisability to occur upon the later to occur of the date such VWAP condition is achieved and the third anniversary of the date of grant.
F4: The option to purchase shares of the Issuer's Common Stock was granted under the Plan. Options to purchase 115,000 shares of the Issuer's Common Stock will vest and become exercisable only if, on or before June 16, 2033, the Common Stock achieves a VWAP of at least $80.00 per share over a 20 consecutive trading day measurement period, with any such vesting and exercisability to occur upon the later to occur of the date such VWAP condition is achieved and the third anniversary of the date of grant.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 16, 2026 Filed Jun 18, 2026 20:17 UTC | Cadre Holdings, Inc. CDRE · Entity 4819 | GrantStock Option (right to purchase) · Derivative | 115,000 | $0.00 Strike: $28.75 | $0.00 |
DisclosureSEC source: 0001104659-26-075743 · tm2618182-1_4seq1.xml · derivative · entry 4 Browers Blaine · CIK 0001874169 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 115,000 Underlying: Common Stock · 115,000 shares Expires 2033-06-16 F4 · derivative.exercise_date: The option to purchase shares of the Issuer's Common Stock was granted under the Plan. Options to purchase 115,000 shares of the Issuer's Common Stock will vest and become exercisable only if, on or before June 16, 2033, the Common Stock achieves a VWAP of at least $80.00 per share over a 20 consecutive trading day measurement period, with any such vesting and exercisability to occur upon the later to occur of the date such VWAP condition is achieved and the third anniversary of the date of grant. Read SEC document |
| June 16, 2026 Filed Jun 18, 2026 20:17 UTC | Cadre Holdings, Inc. CDRE · Entity 4819 | GrantStock Option (right to purchase) · Derivative | 92,500 | $0.00 Strike: $28.75 | $0.00 |
DisclosureSEC source: 0001104659-26-075743 · tm2618182-1_4seq1.xml · derivative · entry 3 Browers Blaine · CIK 0001874169 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 92,500 Underlying: Common Stock · 92,500 shares Expires 2033-06-16 F3 · derivative.exercise_date: The option to purchase shares of the Issuer's Common Stock was granted under the Plan. Options to purchase 92,500 shares of the Issuer's Common Stock will vest and become exercisable only if, on or before June 16, 2033, the Common Stock achieves a VWAP of at least $60.00 per share over a 20 consecutive trading day measurement period, with any such vesting and exercisability to occur upon the later to occur of the date such VWAP condition is achieved and the third anniversary of the date of grant. Read SEC document |
| June 16, 2026 Filed Jun 18, 2026 20:17 UTC | Cadre Holdings, Inc. CDRE · Entity 4819 | GrantRestricted Stock Units · Derivative | 69,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-26-075743 · tm2618182-1_4seq1.xml · derivative · entry 2 Browers Blaine · CIK 0001874169 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 69,500 Underlying: Common Stock · 69,500 shares Expires not disclosed F2 · derivative.exercise_price: Represents an award of restricted stock units granted under the Plan, consisting of 69,500 restricted stock units relating to shares of the Issuer's Common Stock. The restricted stock units will vest only if, on or before June 16, 2033, the Common Stock achieves a VWAP of at least $80.00 per share over a 20 consecutive trading day measurement period, with any such vesting to occur upon the later to occur of the date such VWAP condition is achieved and the third anniversary of the date of grant. F2 · derivative.exercise_date: Represents an award of restricted stock units granted under the Plan, consisting of 69,500 restricted stock units relating to shares of the Issuer's Common Stock. The restricted stock units will vest only if, on or before June 16, 2033, the Common Stock achieves a VWAP of at least $80.00 per share over a 20 consecutive trading day measurement period, with any such vesting to occur upon the later to occur of the date such VWAP condition is achieved and the third anniversary of the date of grant. F2 · derivative.expiration_date: Represents an award of restricted stock units granted under the Plan, consisting of 69,500 restricted stock units relating to shares of the Issuer's Common Stock. The restricted stock units will vest only if, on or before June 16, 2033, the Common Stock achieves a VWAP of at least $80.00 per share over a 20 consecutive trading day measurement period, with any such vesting to occur upon the later to occur of the date such VWAP condition is achieved and the third anniversary of the date of grant. Read SEC document |
| June 16, 2026 Filed Jun 18, 2026 20:17 UTC | Cadre Holdings, Inc. CDRE · Entity 4819 | GrantRestricted Stock Units · Derivative | 48,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-26-075743 · tm2618182-1_4seq1.xml · derivative · entry 1 Browers Blaine · CIK 0001874169 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 48,500 Underlying: Common Stock · 48,500 shares Expires not disclosed F1 · derivative.exercise_price: Represents an award of restricted stock units granted under Cadre Holdings, Inc.'s (the "Issuer") 2021 Stock Incentive Plan (the "Plan"), consisting of 48,500 restricted stock units relating to shares of the Issuer's common stock, par value $0.0001 per share ("Common Stock"). The restricted stock units will vest only if, on or before June 16, 2033, the Common Stock achieves a volume-weighted average trading price ("VWAP") of at least $60.00 per share over a 20 consecutive trading day measurement period, with any such vesting to occur upon the later to occur of the date such VWAP condition is achieved and the third anniversary of the date of grant. F1 · derivative.exercise_date: Represents an award of restricted stock units granted under Cadre Holdings, Inc.'s (the "Issuer") 2021 Stock Incentive Plan (the "Plan"), consisting of 48,500 restricted stock units relating to shares of the Issuer's common stock, par value $0.0001 per share ("Common Stock"). The restricted stock units will vest only if, on or before June 16, 2033, the Common Stock achieves a volume-weighted average trading price ("VWAP") of at least $60.00 per share over a 20 consecutive trading day measurement period, with any such vesting to occur upon the later to occur of the date such VWAP condition is achieved and the third anniversary of the date of grant. F1 · derivative.expiration_date: Represents an award of restricted stock units granted under Cadre Holdings, Inc.'s (the "Issuer") 2021 Stock Incentive Plan (the "Plan"), consisting of 48,500 restricted stock units relating to shares of the Issuer's common stock, par value $0.0001 per share ("Common Stock"). The restricted stock units will vest only if, on or before June 16, 2033, the Common Stock achieves a volume-weighted average trading price ("VWAP") of at least $60.00 per share over a 20 consecutive trading day measurement period, with any such vesting to occur upon the later to occur of the date such VWAP condition is achieved and the third anniversary of the date of grant. Read SEC document |
| March 30, 2026 Filed Apr 1, 2026 20:15 UTC | Cadre Holdings, Inc. CDRE · Entity 4819 | GrantStock Option (right to purchase) · Derivative | 49,664 | $0.00 Strike: $29.39 | $0.00 |
DisclosureSEC source: 0001104659-26-038517 · tm2610821-1_4seq1.xml · derivative · entry 2 Browers Blaine · CIK 0001874169 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 49,664 Underlying: Common Stock · 49,664 shares Expires 2036-03-30 F2 · derivative.exercise_date: The option to purchase shares of the Issuer's Common Stock was granted under the Plan. Options to purchase 16,556 shares of the Issuer's Common Stock will vest and become exercisable on March 30, 2027, and options to purchase 16,554 shares of the Issuer's Common Stock will vest and become exercisable on each of March 30, 2028, and March 30, 2029, respectively. Read SEC document |
| March 30, 2026 Filed Apr 1, 2026 20:15 UTC | Cadre Holdings, Inc. CDRE · Entity 4819 | GrantRestricted Stock Units · Derivative | 15,333 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-26-038517 · tm2610821-1_4seq1.xml · derivative · entry 1 Browers Blaine · CIK 0001874169 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,333 Underlying: Common Stock · 15,333 shares Expires not disclosed F1 · derivative.exercise_price: Comprised of a restricted stock units award granted under Cadre Holdings, Inc.'s (the "Issuer") 2021 Stock Incentive Plan (the "Plan"), consisting of 15,333 restricted shares of the Issuer's common stock, par value $0.0001 per share ("Common Stock"). Of those shares, 5,111 shares will vest and become non-forfeitable on each of March 30, 2027, March 30, 2028, and March 30, 2029, respectively. F1 · derivative.exercise_date: Comprised of a restricted stock units award granted under Cadre Holdings, Inc.'s (the "Issuer") 2021 Stock Incentive Plan (the "Plan"), consisting of 15,333 restricted shares of the Issuer's common stock, par value $0.0001 per share ("Common Stock"). Of those shares, 5,111 shares will vest and become non-forfeitable on each of March 30, 2027, March 30, 2028, and March 30, 2029, respectively. F1 · derivative.expiration_date: Comprised of a restricted stock units award granted under Cadre Holdings, Inc.'s (the "Issuer") 2021 Stock Incentive Plan (the "Plan"), consisting of 15,333 restricted shares of the Issuer's common stock, par value $0.0001 per share ("Common Stock"). Of those shares, 5,111 shares will vest and become non-forfeitable on each of March 30, 2027, March 30, 2028, and March 30, 2029, respectively. Read SEC document |
| March 18, 2026 Filed Mar 20, 2026 20:17 UTC | Cadre Holdings, Inc. CDRE · Entity 4819 | Exercise / conversionRestricted Stock Units · Derivative | 3,282 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-26-032732 · tm269192-2_4seq1.xml · derivative · entry 3 Browers Blaine · CIK 0001874169 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,282 Underlying: Common Stock · 3,282 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Comprised of a restricted stock units award granted on March 18, 2024 (the "2024 Restricted Stock Units Award"), under the Issuer's 2021 Stock Incentive Plan (the "Plan"), covering 9,846 shares of Common Stock. Of those shares, 3,282 shares vested and became non-forfeitable on each of March 18, 2025, and March 18, 2026, and 3,282 shares will vest and become non-forfeitable on March 18, 2027. F1 · derivative.exercise_date: Comprised of a restricted stock units award granted on March 18, 2024 (the "2024 Restricted Stock Units Award"), under the Issuer's 2021 Stock Incentive Plan (the "Plan"), covering 9,846 shares of Common Stock. Of those shares, 3,282 shares vested and became non-forfeitable on each of March 18, 2025, and March 18, 2026, and 3,282 shares will vest and become non-forfeitable on March 18, 2027. F1 · derivative.expiration_date: Comprised of a restricted stock units award granted on March 18, 2024 (the "2024 Restricted Stock Units Award"), under the Issuer's 2021 Stock Incentive Plan (the "Plan"), covering 9,846 shares of Common Stock. Of those shares, 3,282 shares vested and became non-forfeitable on each of March 18, 2025, and March 18, 2026, and 3,282 shares will vest and become non-forfeitable on March 18, 2027. Read SEC document |
| March 18, 2026 Filed Mar 20, 2026 20:17 UTC | Cadre Holdings, Inc. CDRE · Entity 4819 | Tax withholdingCommon Stock | 1,292 | $32.22 | $41,628.24 |
DisclosureSEC source: 0001104659-26-032732 · tm269192-2_4seq1.xml · nonDerivative · entry 2 Browers Blaine · CIK 0001874169 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 69,653 F2 · shares: Represents the number of shares of Common Stock withheld by the Issuer to satisfy the tax withholding obligations incurred by Mr. Browers as a result of the vesting on March 18, 2026, of a portion of the 2024 Restricted Stock Units Award. Read SEC document |
| March 18, 2026 Filed Mar 20, 2026 20:17 UTC | Cadre Holdings, Inc. CDRE · Entity 4819 | Exercise / conversionCommon Stock, par value $0.0001 per share ("Common Stock") | 3,282 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-26-032732 · tm269192-2_4seq1.xml · nonDerivative · entry 1 Browers Blaine · CIK 0001874169 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 70,945 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Comprised of a restricted stock units award granted on March 18, 2024 (the "2024 Restricted Stock Units Award"), under the Issuer's 2021 Stock Incentive Plan (the "Plan"), covering 9,846 shares of Common Stock. Of those shares, 3,282 shares vested and became non-forfeitable on each of March 18, 2025, and March 18, 2026, and 3,282 shares will vest and become non-forfeitable on March 18, 2027. Read SEC document |
| March 13, 2026 Filed Mar 17, 2026 21:47 UTC | Cadre Holdings, Inc. CDRE · Entity 4819 | Exercise / conversionRestricted Stock Units · Derivative | 4,309 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-26-029628 · tm268980-1_4seq1.xml · derivative · entry 6 Browers Blaine · CIK 0001874169 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,616 Underlying: Common Stock · 4,309 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Comprised of a restricted stock units award granted on March 13, 2025 (the "2025 Restricted Stock Units Award") under the Plan, covering 12,925 shares of Common Stock. Of those shares, 4,309 shares vested and became non-forfeitable on March 13, 2026, and 4,308 shares will vest and become non-forfeitable on each of March 13, 2027 and March 13, 2028. F3 · derivative.exercise_date: Comprised of a restricted stock units award granted on March 13, 2025 (the "2025 Restricted Stock Units Award") under the Plan, covering 12,925 shares of Common Stock. Of those shares, 4,309 shares vested and became non-forfeitable on March 13, 2026, and 4,308 shares will vest and become non-forfeitable on each of March 13, 2027 and March 13, 2028. F3 · derivative.expiration_date: Comprised of a restricted stock units award granted on March 13, 2025 (the "2025 Restricted Stock Units Award") under the Plan, covering 12,925 shares of Common Stock. Of those shares, 4,309 shares vested and became non-forfeitable on March 13, 2026, and 4,308 shares will vest and become non-forfeitable on each of March 13, 2027 and March 13, 2028. Read SEC document |
| March 13, 2026 Filed Mar 17, 2026 21:47 UTC | Cadre Holdings, Inc. CDRE · Entity 4819 | Exercise / conversionRestricted Stock Units · Derivative | 3,393 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-26-029628 · tm268980-1_4seq1.xml · derivative · entry 5 Browers Blaine · CIK 0001874169 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,393 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Comprised of a restricted stock units award granted on March 13, 2023 (the "2023 Restricted Stock Units Award"), under the Issuer's 2021 Stock Incentive Plan (the "Plan"), covering 10,177 shares of Common Stock. Of those shares, 3,391 shares vested and became non-forfeitable on March 13, 2024, and 3,393 shares vested and became non-forfeitable on each of March 13, 2025 and March 13, 2026. F1 · derivative.exercise_date: Comprised of a restricted stock units award granted on March 13, 2023 (the "2023 Restricted Stock Units Award"), under the Issuer's 2021 Stock Incentive Plan (the "Plan"), covering 10,177 shares of Common Stock. Of those shares, 3,391 shares vested and became non-forfeitable on March 13, 2024, and 3,393 shares vested and became non-forfeitable on each of March 13, 2025 and March 13, 2026. F1 · derivative.expiration_date: Comprised of a restricted stock units award granted on March 13, 2023 (the "2023 Restricted Stock Units Award"), under the Issuer's 2021 Stock Incentive Plan (the "Plan"), covering 10,177 shares of Common Stock. Of those shares, 3,391 shares vested and became non-forfeitable on March 13, 2024, and 3,393 shares vested and became non-forfeitable on each of March 13, 2025 and March 13, 2026. Read SEC document |
| March 13, 2026 Filed Mar 17, 2026 21:47 UTC | Cadre Holdings, Inc. CDRE · Entity 4819 | Tax withholdingCommon Stock | 1,845 | $31.65 | $58,394.25 |
DisclosureSEC source: 0001104659-26-029628 · tm268980-1_4seq1.xml · nonDerivative · entry 4 Browers Blaine · CIK 0001874169 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 67,663 F4 · shares: Represents the number of shares of Common Stock withheld by the Issuer to satisfy the tax withholding obligations incurred by Mr. Browers as a result of the vesting on March 13, 2026, of a portion of the 2025 Restricted Stock Units Award. Read SEC document |
| March 13, 2026 Filed Mar 17, 2026 21:47 UTC | Cadre Holdings, Inc. CDRE · Entity 4819 | Exercise / conversionCommon Stock | 4,309 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-26-029628 · tm268980-1_4seq1.xml · nonDerivative · entry 3 Browers Blaine · CIK 0001874169 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 69,508 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · price: Comprised of a restricted stock units award granted on March 13, 2025 (the "2025 Restricted Stock Units Award") under the Plan, covering 12,925 shares of Common Stock. Of those shares, 4,309 shares vested and became non-forfeitable on March 13, 2026, and 4,308 shares will vest and become non-forfeitable on each of March 13, 2027 and March 13, 2028. Read SEC document |
| March 13, 2026 Filed Mar 17, 2026 21:47 UTC | Cadre Holdings, Inc. CDRE · Entity 4819 | Tax withholdingCommon Stock | 1,336 | $31.65 | $42,284.40 |
DisclosureSEC source: 0001104659-26-029628 · tm268980-1_4seq1.xml · nonDerivative · entry 2 Browers Blaine · CIK 0001874169 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 65,199 F2 · shares: Represents the number of shares of Common Stock withheld by the Issuer to satisfy the tax withholding obligations incurred by Mr. Browers as a result of the vesting on March 13, 2026, of a portion of the 2023 Restricted Stock Units Award. Read SEC document |
| March 13, 2026 Filed Mar 17, 2026 21:47 UTC | Cadre Holdings, Inc. CDRE · Entity 4819 | Exercise / conversionCommon Stock, par value $0.0001 per share ("Common Stock") | 3,393 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-26-029628 · tm268980-1_4seq1.xml · nonDerivative · entry 1 Browers Blaine · CIK 0001874169 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 66,535 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Comprised of a restricted stock units award granted on March 13, 2023 (the "2023 Restricted Stock Units Award"), under the Issuer's 2021 Stock Incentive Plan (the "Plan"), covering 10,177 shares of Common Stock. Of those shares, 3,391 shares vested and became non-forfeitable on March 13, 2024, and 3,393 shares vested and became non-forfeitable on each of March 13, 2025 and March 13, 2026. Read SEC document |
| December 12, 2025 Filed Dec 16, 2025 21:15 UTC | Cadre Holdings, Inc. CDRE · Entity 4819 | SaleCommon Stock, par value $0.0001 per share ("Common Stock") | 20,435 | $43.79 | $894,848.65 |
DisclosureSEC source: 0001104659-25-121589 · tm2533534-1_4seq1.xml · nonDerivative · entry 1 Browers Blaine · CIK 0001874169 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 63,142 F1 · price: The price reported in Column 4 is a weighted average price per share. These shares of Common Stock were sold in multiple transactions at prices ranging from $43.41 to $44.31 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares of Common Stock sold at each separate price within the ranges set forth in this footnote (1) to this Form 4. Read SEC document |
| March 18, 2025 Filed Mar 20, 2025 20:15 UTC | Cadre Holdings, Inc. CDRE · Entity 4819 | Exercise / conversionRestricted Stock Units · Derivative | 3,282 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-026141 · tm259720-2_4seq1.xml · derivative · entry 3 Browers Blaine · CIK 0001874169 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,564 Underlying: Common Stock · 3,282 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Comprised of a restricted stock units award (the "Restricted Stock Award") granted under Cadre Holdings, Inc.'s (the "Issuer") 2021 Stock Incentive Plan consisting of 9,846 shares of the Issuer's common stock, par value $0.0001 per share (the "Common Stock"). 3,282 restricted shares of Common Stock vested and became non-forfeitable on March 18, 2025, and 3,282 restricted shares of Common Stock will vest and become non-forfeitable on each of March 18, 2026 and March 18, 2027, respectively. F1 · derivative.exercise_date: Comprised of a restricted stock units award (the "Restricted Stock Award") granted under Cadre Holdings, Inc.'s (the "Issuer") 2021 Stock Incentive Plan consisting of 9,846 shares of the Issuer's common stock, par value $0.0001 per share (the "Common Stock"). 3,282 restricted shares of Common Stock vested and became non-forfeitable on March 18, 2025, and 3,282 restricted shares of Common Stock will vest and become non-forfeitable on each of March 18, 2026 and March 18, 2027, respectively. F1 · derivative.expiration_date: Comprised of a restricted stock units award (the "Restricted Stock Award") granted under Cadre Holdings, Inc.'s (the "Issuer") 2021 Stock Incentive Plan consisting of 9,846 shares of the Issuer's common stock, par value $0.0001 per share (the "Common Stock"). 3,282 restricted shares of Common Stock vested and became non-forfeitable on March 18, 2025, and 3,282 restricted shares of Common Stock will vest and become non-forfeitable on each of March 18, 2026 and March 18, 2027, respectively. Read SEC document |
| March 18, 2025 Filed Mar 20, 2025 20:15 UTC | Cadre Holdings, Inc. CDRE · Entity 4819 | Tax withholdingCommon Stock | 800 | $32.33 | $25,864.00 |
DisclosureSEC source: 0001104659-25-026141 · tm259720-2_4seq1.xml · nonDerivative · entry 2 Browers Blaine · CIK 0001874169 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 84,578 F2 · shares: Represents the number of shares of Common Stock withheld by the Issuer to satisfy the tax withholding obligations incurred by Mr. Browers as a result of the vesting, on March 18, 2025, of a portion of the Restricted Stock Award. Read SEC document |
| March 18, 2025 Filed Mar 20, 2025 20:15 UTC | Cadre Holdings, Inc. CDRE · Entity 4819 | Exercise / conversionCommon Stock, par value $0.0001 per share ("Common Stock") | 3,282 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-25-026141 · tm259720-2_4seq1.xml · nonDerivative · entry 1 Browers Blaine · CIK 0001874169 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 85,378 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Comprised of a restricted stock units award (the "Restricted Stock Award") granted under Cadre Holdings, Inc.'s (the "Issuer") 2021 Stock Incentive Plan consisting of 9,846 shares of the Issuer's common stock, par value $0.0001 per share (the "Common Stock"). 3,282 restricted shares of Common Stock vested and became non-forfeitable on March 18, 2025, and 3,282 restricted shares of Common Stock will vest and become non-forfeitable on each of March 18, 2026 and March 18, 2027, respectively. Read SEC document |
| March 13, 2025 Filed Mar 17, 2025 20:16 UTC | Cadre Holdings, Inc. CDRE · Entity 4819 | GrantRestricted Stock Units · Derivative | 12,841 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-024429 · tm259280-3_4seq1.xml · derivative · entry 5 Browers Blaine · CIK 0001874169 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,841 Underlying: Common Stock · 12,841 shares Expires not disclosed F4 · derivative.exercise_price: Comprised of a restricted stock units award granted under the Plan consisting of 12,841 restricted shares of the Issuer's Common Stock. 4,281 restricted shares of the Issuer's Common Stock will vest and become non-forfeitable on March 13, 2026, and 4,280 restricted shares of the Issuer's Common Stock will vest and become non-forfeitable on each of March 13, 2027, and March 13, 2028, respectively. F4 · derivative.exercise_date: Comprised of a restricted stock units award granted under the Plan consisting of 12,841 restricted shares of the Issuer's Common Stock. 4,281 restricted shares of the Issuer's Common Stock will vest and become non-forfeitable on March 13, 2026, and 4,280 restricted shares of the Issuer's Common Stock will vest and become non-forfeitable on each of March 13, 2027, and March 13, 2028, respectively. F4 · derivative.expiration_date: Comprised of a restricted stock units award granted under the Plan consisting of 12,841 restricted shares of the Issuer's Common Stock. 4,281 restricted shares of the Issuer's Common Stock will vest and become non-forfeitable on March 13, 2026, and 4,280 restricted shares of the Issuer's Common Stock will vest and become non-forfeitable on each of March 13, 2027, and March 13, 2028, respectively. Read SEC document |
| March 13, 2025 Filed Mar 17, 2025 20:16 UTC | Cadre Holdings, Inc. CDRE · Entity 4819 | GrantStock Option (right to purchase) · Derivative | 40,101 | $0.00 Strike: $34.91 | $0.00 |
DisclosureSEC source: 0001104659-25-024429 · tm259280-3_4seq1.xml · derivative · entry 4 Browers Blaine · CIK 0001874169 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,141 Underlying: Common Stock · 40,141 shares Expires 2035-03-13 F3 · derivative.exercise_date: The option to purchase shares of the Issuer's Common Stock was granted under the Plan. Options to purchase 13,367 shares of the Issuer's Common Stock will vest and become exercisable on each of March 13, 2026, March 13, 2027 and March 13, 2028, respectively. Read SEC document |
| March 13, 2025 Filed Mar 17, 2025 20:16 UTC | Cadre Holdings, Inc. CDRE · Entity 4819 | Exercise / conversionRestricted Stock Units · Derivative | 3,393 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-024429 · tm259280-3_4seq1.xml · derivative · entry 3 Browers Blaine · CIK 0001874169 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,393 Underlying: Common Stock · 3,393 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Comprised of a restricted stock units award previously granted on March 13, 2023 (the "Restricted Stock Award"), under the Issuer's 2021 Stock Incentive Plan (the "Plan") consisting of 10,177 restricted shares of the Issuer's common stock, par value $0.0001 per share (the "Common Stock"). 3,391 restricted shares of Common Stock vested and became non-forfeitable on March 13, 2024, 3,393 restricted shares of Common Stock vested and became non-forfeitable on March 13, 2025, and 3,393 restricted shares of Common Stock will vest and become non-forfeitable on March 13, 2026. F1 · derivative.exercise_date: Comprised of a restricted stock units award previously granted on March 13, 2023 (the "Restricted Stock Award"), under the Issuer's 2021 Stock Incentive Plan (the "Plan") consisting of 10,177 restricted shares of the Issuer's common stock, par value $0.0001 per share (the "Common Stock"). 3,391 restricted shares of Common Stock vested and became non-forfeitable on March 13, 2024, 3,393 restricted shares of Common Stock vested and became non-forfeitable on March 13, 2025, and 3,393 restricted shares of Common Stock will vest and become non-forfeitable on March 13, 2026. F1 · derivative.expiration_date: Comprised of a restricted stock units award previously granted on March 13, 2023 (the "Restricted Stock Award"), under the Issuer's 2021 Stock Incentive Plan (the "Plan") consisting of 10,177 restricted shares of the Issuer's common stock, par value $0.0001 per share (the "Common Stock"). 3,391 restricted shares of Common Stock vested and became non-forfeitable on March 13, 2024, 3,393 restricted shares of Common Stock vested and became non-forfeitable on March 13, 2025, and 3,393 restricted shares of Common Stock will vest and become non-forfeitable on March 13, 2026. Read SEC document |
| March 13, 2025 Filed Mar 17, 2025 20:16 UTC | Cadre Holdings, Inc. CDRE · Entity 4819 | Tax withholdingCommon Stock | 826 | $34.91 | $28,835.66 |
DisclosureSEC source: 0001104659-25-024429 · tm259280-3_4seq1.xml · nonDerivative · entry 2 Browers Blaine · CIK 0001874169 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 82,096 F2 · shares: Represents the number of shares of Common Stock withheld by the Issuer to satisfy the tax withholding obligations incurred by Mr. Browers as a result of the vesting on March 13, 2025, of a portion of the Restricted Stock Award. Read SEC document |
| March 13, 2025 Filed Mar 17, 2025 20:16 UTC | Cadre Holdings, Inc. CDRE · Entity 4819 | Exercise / conversionCommon Stock, par value $0.0001 per share ("Common Stock") | 3,393 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-25-024429 · tm259280-3_4seq1.xml · nonDerivative · entry 1 Browers Blaine · CIK 0001874169 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 82,922 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Comprised of a restricted stock units award previously granted on March 13, 2023 (the "Restricted Stock Award"), under the Issuer's 2021 Stock Incentive Plan (the "Plan") consisting of 10,177 restricted shares of the Issuer's common stock, par value $0.0001 per share (the "Common Stock"). 3,391 restricted shares of Common Stock vested and became non-forfeitable on March 13, 2024, 3,393 restricted shares of Common Stock vested and became non-forfeitable on March 13, 2025, and 3,393 restricted shares of Common Stock will vest and become non-forfeitable on March 13, 2026. Read SEC document |
| March 13, 2025 Filed Apr 24, 2025 20:47 UTC Amendment | Cadre Holdings, Inc. CDRE · Entity 4819 | GrantRestricted Stock Units · Derivative | 12,925 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-038720 · tm2513047-3_4aseq1.xml · derivative · entry 2 Browers Blaine · CIK 0001874169 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,925 Underlying: Common Stock · 12,925 shares Expires not disclosed F2 · derivative.exercise_price: Comprised of a restricted stock units award granted under the Plan consisting of 12,925 restricted shares of the Issuer's Common Stock. 4,309 restricted shares of the Issuer's Common Stock will vest and become non-forfeitable on March 13, 2026, and 4,308 restricted shares of the Issuer's Common will vest and become non-forfeitable on each if March 13, 2027 and March 13, 2028, respectively. F3 · derivative.exercise_price: This amendment is being filed to correct the number of options and restricted stock units granted on March 13, 2025 and reported in the original Form 4 filed on March 17, 2025. Footnotes 3 and 4 have been renumbered and revised accordingly. F2 · derivative.exercise_date: Comprised of a restricted stock units award granted under the Plan consisting of 12,925 restricted shares of the Issuer's Common Stock. 4,309 restricted shares of the Issuer's Common Stock will vest and become non-forfeitable on March 13, 2026, and 4,308 restricted shares of the Issuer's Common will vest and become non-forfeitable on each if March 13, 2027 and March 13, 2028, respectively. F3 · derivative.exercise_date: This amendment is being filed to correct the number of options and restricted stock units granted on March 13, 2025 and reported in the original Form 4 filed on March 17, 2025. Footnotes 3 and 4 have been renumbered and revised accordingly. F2 · derivative.expiration_date: Comprised of a restricted stock units award granted under the Plan consisting of 12,925 restricted shares of the Issuer's Common Stock. 4,309 restricted shares of the Issuer's Common Stock will vest and become non-forfeitable on March 13, 2026, and 4,308 restricted shares of the Issuer's Common will vest and become non-forfeitable on each if March 13, 2027 and March 13, 2028, respectively. F3 · derivative.expiration_date: This amendment is being filed to correct the number of options and restricted stock units granted on March 13, 2025 and reported in the original Form 4 filed on March 17, 2025. Footnotes 3 and 4 have been renumbered and revised accordingly. Read SEC document |
| March 13, 2025 Filed Apr 24, 2025 20:47 UTC Amendment | Cadre Holdings, Inc. CDRE · Entity 4819 | GrantStock Option (right to purchase) · Derivative | 40,304 | $0.00 Strike: $33.85 | $0.00 |
DisclosureSEC source: 0001104659-25-038720 · tm2513047-3_4aseq1.xml · derivative · entry 1 Browers Blaine · CIK 0001874169 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,304 Underlying: Common Stock · 40,304 shares Expires 2035-03-13 F1 · derivative.exercise_date: The option to purchase 40,304 shares of the Issuer's Common Stock, par value $0.0001 per share ("Common Stock"), was granted under the Plan. Options to purchase 13,434 shares of the Issuer's Common Stock will vest and become exercisable on March 13, 2026, and options to purchase 13,435 shares of the Issuer's Common Stock will vest and become exercisable on each of March 13, 2027, and March 13, 2028, respectively. F3 · derivative.exercise_date: This amendment is being filed to correct the number of options and restricted stock units granted on March 13, 2025 and reported in the original Form 4 filed on March 17, 2025. Footnotes 3 and 4 have been renumbered and revised accordingly. Read SEC document |
| March 09, 2025 Filed Mar 11, 2025 20:15 UTC | Cadre Holdings, Inc. CDRE · Entity 4819 | Exercise / conversionRestricted Stock Units · Derivative | 2,918 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-022568 · tm258792-3_4seq1.xml · derivative · entry 3 Browers Blaine · CIK 0001874169 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,918 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Comprised of a restricted stock units award previously granted on March 9, 2022, under the Issuer's 2021 Stock Incentive Plan (the "Restricted Stock Award") consisting of 8,755 restricted shares of Common Stock. 2,919, 2,918 and 2,918 restricted shares of Common Stock vested and became non-forfeitable on each of March 9, 2023, March 9, 2024, and March 9, 2025, respectively. F1 · derivative.exercise_date: Comprised of a restricted stock units award previously granted on March 9, 2022, under the Issuer's 2021 Stock Incentive Plan (the "Restricted Stock Award") consisting of 8,755 restricted shares of Common Stock. 2,919, 2,918 and 2,918 restricted shares of Common Stock vested and became non-forfeitable on each of March 9, 2023, March 9, 2024, and March 9, 2025, respectively. F1 · derivative.expiration_date: Comprised of a restricted stock units award previously granted on March 9, 2022, under the Issuer's 2021 Stock Incentive Plan (the "Restricted Stock Award") consisting of 8,755 restricted shares of Common Stock. 2,919, 2,918 and 2,918 restricted shares of Common Stock vested and became non-forfeitable on each of March 9, 2023, March 9, 2024, and March 9, 2025, respectively. Read SEC document |
| March 09, 2025 Filed Mar 11, 2025 20:15 UTC | Cadre Holdings, Inc. CDRE · Entity 4819 | Tax withholdingCommon Stock | 1,265 | $34.02 | $43,035.30 |
DisclosureSEC source: 0001104659-25-022568 · tm258792-3_4seq1.xml · nonDerivative · entry 2 Browers Blaine · CIK 0001874169 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 79,529 F2 · shares: Represents the number of shares of Common Stock withheld by the Issuer to satisfy the tax withholding obligations incurred by Mr. Browers as a result of the vesting on March 9, 2025, of a portion of the Restricted Stock Award. Read SEC document |
| March 09, 2025 Filed Mar 11, 2025 20:15 UTC | Cadre Holdings, Inc. CDRE · Entity 4819 | Exercise / conversionCommon Stock, par value $0.0001 per share ("Common Stock") | 2,918 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-25-022568 · tm258792-3_4seq1.xml · nonDerivative · entry 1 Browers Blaine · CIK 0001874169 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 80,794 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Comprised of a restricted stock units award previously granted on March 9, 2022, under the Issuer's 2021 Stock Incentive Plan (the "Restricted Stock Award") consisting of 8,755 restricted shares of Common Stock. 2,919, 2,918 and 2,918 restricted shares of Common Stock vested and became non-forfeitable on each of March 9, 2023, March 9, 2024, and March 9, 2025, respectively. Read SEC document |
| November 12, 2024 Filed Nov 13, 2024 21:15 UTC | Cadre Holdings, Inc. CDRE · Entity 4819 | SaleCommon Stock, par value $.0001 per share ("Common Stock") | 30,000 | $34.06 | $1,021,704.00 |
DisclosureSEC source: 0001104659-24-117711 · tm2428292-1_4seq1.xml · nonDerivative · entry 1 Browers Blaine · CIK 0001874169 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 77,876 F1 · price: The price reported in Column 4 is a weighted average price. These shares of Common Stock were sold in multiple transactions at prices ranging from $33.69- $35.00. The Reporting Person undertakes to provide to Cadre Holdings, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares of Common Stock sold at each separate price within the ranges set forth in this footnote (1) to this Form 4. Read SEC document |
| March 18, 2024 Filed Mar 20, 2024 20:16 UTC | Cadre Holdings, Inc. CDRE · Entity 4819 | GrantStock Option (right to purchase) · Derivative | 31,023 | $0.00 Strike: $34.66 | $0.00 |
DisclosureSEC source: 0001104659-24-036708 · tm249207-5_4seq1.xml · derivative · entry 5 Browers Blaine · CIK 0001874169 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,023 Underlying: Common Stock · 31,023 shares Expires 2034-03-18 F4 · derivative.exercise_date: The option to purchase shares of the Issuer's Common Stock was granted under the Plan. Options to purchase 10,341 shares of the Issuer's Common Stock will vest and become exercisable on each of March 18, 2025, March 18, 2026 and March 18, 2027, respectively. Read SEC document |
| March 18, 2024 Filed Mar 20, 2024 20:16 UTC | Cadre Holdings, Inc. CDRE · Entity 4819 | GrantRestricted Stock Units · Derivative | 9,846 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-036708 · tm249207-5_4seq1.xml · derivative · entry 4 Browers Blaine · CIK 0001874169 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,846 Underlying: Common Stock · 9,846 shares Expires not disclosed F3 · derivative.exercise_price: Comprised of a restricted stock units award granted under the Issuer's 2021 Stock Incentive Plan (the "Plan") consisting of 9,846 shares of the Issuer's Common Stock. 3,282 shares of the Issuer's Common Stock will vest and become non-forfeitable on each of March 18, 2025, March 18, 2026 and March 13, 2027, respectively. F3 · derivative.exercise_date: Comprised of a restricted stock units award granted under the Issuer's 2021 Stock Incentive Plan (the "Plan") consisting of 9,846 shares of the Issuer's Common Stock. 3,282 shares of the Issuer's Common Stock will vest and become non-forfeitable on each of March 18, 2025, March 18, 2026 and March 13, 2027, respectively. F3 · derivative.expiration_date: Comprised of a restricted stock units award granted under the Issuer's 2021 Stock Incentive Plan (the "Plan") consisting of 9,846 shares of the Issuer's Common Stock. 3,282 shares of the Issuer's Common Stock will vest and become non-forfeitable on each of March 18, 2025, March 18, 2026 and March 13, 2027, respectively. Read SEC document |
| March 18, 2024 Filed Mar 20, 2024 20:16 UTC | Cadre Holdings, Inc. CDRE · Entity 4819 | Exercise / conversionPhantom Stock · Derivative | 55,333 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-036708 · tm249207-5_4seq1.xml · derivative · entry 3 Browers Blaine · CIK 0001874169 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 55,333 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: On March 9, 2022, the Reporting Person was granted a phantom stock award under the Safariland Group Amended and Restated 2021 Phantom Restricted Share Plan consisting of 166,000 shares of phantom stock. Each share of phantom stock is the economic equivalent of one share of Cadre Holdings, Inc. (the "Issuer") Common Stock. 55,334 shares of phantom stock vested and became non-forfeitable on March 18, 2022, and 55,333 shares of phantom stock vested and became non-forfeitable on each of March 18, 2023 and March 18, 2024, respectively. F1 · derivative.exercise_date: On March 9, 2022, the Reporting Person was granted a phantom stock award under the Safariland Group Amended and Restated 2021 Phantom Restricted Share Plan consisting of 166,000 shares of phantom stock. Each share of phantom stock is the economic equivalent of one share of Cadre Holdings, Inc. (the "Issuer") Common Stock. 55,334 shares of phantom stock vested and became non-forfeitable on March 18, 2022, and 55,333 shares of phantom stock vested and became non-forfeitable on each of March 18, 2023 and March 18, 2024, respectively. F1 · derivative.expiration_date: On March 9, 2022, the Reporting Person was granted a phantom stock award under the Safariland Group Amended and Restated 2021 Phantom Restricted Share Plan consisting of 166,000 shares of phantom stock. Each share of phantom stock is the economic equivalent of one share of Cadre Holdings, Inc. (the "Issuer") Common Stock. 55,334 shares of phantom stock vested and became non-forfeitable on March 18, 2022, and 55,333 shares of phantom stock vested and became non-forfeitable on each of March 18, 2023 and March 18, 2024, respectively. Read SEC document |
| March 18, 2024 Filed Mar 20, 2024 20:16 UTC | Cadre Holdings, Inc. CDRE · Entity 4819 | Tax withholdingCommon Stock | 21,774 | $34.66 | $754,686.84 |
DisclosureSEC source: 0001104659-24-036708 · tm249207-5_4seq1.xml · nonDerivative · entry 2 Browers Blaine · CIK 0001874169 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 107,876 F2 · shares: Represents the number of shares of Common Stock withheld by the Issuer to satisfy the tax withholding obligations incurred by Mr. Browers as a result of the vesting on March 18, 2024 of a portion of the phantom stock award. Read SEC document |
| March 18, 2024 Filed Mar 20, 2024 20:16 UTC | Cadre Holdings, Inc. CDRE · Entity 4819 | Exercise / conversionCommon Stock, par value $0.0001 per share ("Common Stock") | 55,333 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-24-036708 · tm249207-5_4seq1.xml · nonDerivative · entry 1 Browers Blaine · CIK 0001874169 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 129,650 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: On March 9, 2022, the Reporting Person was granted a phantom stock award under the Safariland Group Amended and Restated 2021 Phantom Restricted Share Plan consisting of 166,000 shares of phantom stock. Each share of phantom stock is the economic equivalent of one share of Cadre Holdings, Inc. (the "Issuer") Common Stock. 55,334 shares of phantom stock vested and became non-forfeitable on March 18, 2022, and 55,333 shares of phantom stock vested and became non-forfeitable on each of March 18, 2023 and March 18, 2024, respectively. Read SEC document |
| March 13, 2024 Filed Mar 15, 2024 20:15 UTC | Cadre Holdings, Inc. CDRE · Entity 4819 | Exercise / conversionRestricted Stock Units · Derivative | 3,391 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-035007 · tm248943-1_4seq1.xml · derivative · entry 3 Browers Blaine · CIK 0001874169 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,786 Underlying: Common Stock · 3,391 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Comprised of a restricted stock units award previously granted on March 13, 2023 under the Issuer's 2021 Stock Incentive Plan (the "Restricted Stock Award") consisting of 10,177 restricted shares of the Issuer's common stock, par value $0.0001 per share (the "Common Stock"). 3,391 restricted shares of Common Stock vested and became nonforfeitable on March 13, 2024, and 3,393 restricted shares of Common Stock will vest and become non-forfeitable on each of March 13, 2025 and March 13, 2026. F1 · derivative.exercise_date: Comprised of a restricted stock units award previously granted on March 13, 2023 under the Issuer's 2021 Stock Incentive Plan (the "Restricted Stock Award") consisting of 10,177 restricted shares of the Issuer's common stock, par value $0.0001 per share (the "Common Stock"). 3,391 restricted shares of Common Stock vested and became nonforfeitable on March 13, 2024, and 3,393 restricted shares of Common Stock will vest and become non-forfeitable on each of March 13, 2025 and March 13, 2026. F1 · derivative.expiration_date: Comprised of a restricted stock units award previously granted on March 13, 2023 under the Issuer's 2021 Stock Incentive Plan (the "Restricted Stock Award") consisting of 10,177 restricted shares of the Issuer's common stock, par value $0.0001 per share (the "Common Stock"). 3,391 restricted shares of Common Stock vested and became nonforfeitable on March 13, 2024, and 3,393 restricted shares of Common Stock will vest and become non-forfeitable on each of March 13, 2025 and March 13, 2026. Read SEC document |
| March 13, 2024 Filed Mar 15, 2024 20:15 UTC | Cadre Holdings, Inc. CDRE · Entity 4819 | Tax withholdingCommon Stock | 1,333 | $39.49 | $52,640.17 |
DisclosureSEC source: 0001104659-24-035007 · tm248943-1_4seq1.xml · nonDerivative · entry 2 Browers Blaine · CIK 0001874169 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 74,317 F2 · shares: Represents the number of shares of Common Stock withheld by the Issuer to satisfy the tax withholding obligations incurred by Mr. Browers as a result of the vesting on March 13, 2024, of a portion of the Restricted Stock Award. Read SEC document |
| March 13, 2024 Filed Mar 15, 2024 20:15 UTC | Cadre Holdings, Inc. CDRE · Entity 4819 | Exercise / conversionCommon Stock, par value $0.0001 per share ("Common Stock") | 3,391 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-24-035007 · tm248943-1_4seq1.xml · nonDerivative · entry 1 Browers Blaine · CIK 0001874169 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 75,650 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Comprised of a restricted stock units award previously granted on March 13, 2023 under the Issuer's 2021 Stock Incentive Plan (the "Restricted Stock Award") consisting of 10,177 restricted shares of the Issuer's common stock, par value $0.0001 per share (the "Common Stock"). 3,391 restricted shares of Common Stock vested and became nonforfeitable on March 13, 2024, and 3,393 restricted shares of Common Stock will vest and become non-forfeitable on each of March 13, 2025 and March 13, 2026. Read SEC document |
| March 09, 2024 Filed Mar 12, 2024 20:16 UTC | Cadre Holdings, Inc. CDRE · Entity 4819 | Exercise / conversionRestricted Stock Units · Derivative | 2,918 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-033475 · tm248540-3_4seq1.xml · derivative · entry 3 Browers Blaine · CIK 0001874169 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,918 Underlying: Common Stock · 2,918 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Comprised of a restricted stock units award previously granted on March 9, 2022 under the Issuer's 2021 Stock Incentive Plan (the "Restricted Stock Award") consisting of 8,755 restricted shares of Common Stock. 2,919 and 2,918 restricted shares of Common Stock vested and became non-forfeitable on each of March 9, 2023 and March 9, 2024, respectively, and 2,918 restricted shares of Common Stock will vest and become non-forfeitable on March 9, 2025. F1 · derivative.exercise_date: Comprised of a restricted stock units award previously granted on March 9, 2022 under the Issuer's 2021 Stock Incentive Plan (the "Restricted Stock Award") consisting of 8,755 restricted shares of Common Stock. 2,919 and 2,918 restricted shares of Common Stock vested and became non-forfeitable on each of March 9, 2023 and March 9, 2024, respectively, and 2,918 restricted shares of Common Stock will vest and become non-forfeitable on March 9, 2025. F1 · derivative.expiration_date: Comprised of a restricted stock units award previously granted on March 9, 2022 under the Issuer's 2021 Stock Incentive Plan (the "Restricted Stock Award") consisting of 8,755 restricted shares of Common Stock. 2,919 and 2,918 restricted shares of Common Stock vested and became non-forfeitable on each of March 9, 2023 and March 9, 2024, respectively, and 2,918 restricted shares of Common Stock will vest and become non-forfeitable on March 9, 2025. Read SEC document |
| March 09, 2024 Filed Mar 12, 2024 20:16 UTC | Cadre Holdings, Inc. CDRE · Entity 4819 | Tax withholdingCommon Stock | 1,268 | $38.46 | $48,767.28 |
DisclosureSEC source: 0001104659-24-033475 · tm248540-3_4seq1.xml · nonDerivative · entry 2 Browers Blaine · CIK 0001874169 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 72,259 F2 · shares: Represents the number of shares of Common Stock withheld by the Issuer to satisfy the tax withholding obligations incurred by Mr. Browers as a result of the vesting on March 9, 2024 of a portion of the Restricted Stock Award. Read SEC document |
| March 09, 2024 Filed Mar 12, 2024 20:16 UTC | Cadre Holdings, Inc. CDRE · Entity 4819 | Exercise / conversionCommon Stock, par value $0.0001 per share ("Common Stock") | 2,918 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-24-033475 · tm248540-3_4seq1.xml · nonDerivative · entry 1 Browers Blaine · CIK 0001874169 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 73,527 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Comprised of a restricted stock units award previously granted on March 9, 2022 under the Issuer's 2021 Stock Incentive Plan (the "Restricted Stock Award") consisting of 8,755 restricted shares of Common Stock. 2,919 and 2,918 restricted shares of Common Stock vested and became non-forfeitable on each of March 9, 2023 and March 9, 2024, respectively, and 2,918 restricted shares of Common Stock will vest and become non-forfeitable on March 9, 2025. Read SEC document |
| December 12, 2023 Filed Dec 13, 2023 21:15 UTC | Cadre Holdings, Inc. CDRE · Entity 4819 | SaleCommon Stock | 7,564 | $32.05 | $242,430.74 |
DisclosureSEC source: 0001104659-23-125711 · tm2332816-1_4seq1.xml · nonDerivative · entry 2 Browers Blaine · CIK 0001874169 · PRESIDENT 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 70,069 F2 · price: The price reported in Column 4 is a weighted average price. These shares of Common Stock were sold in multiple transactions at prices ranging from $32.00- $32.40. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares of Common Stock sold at each separate price within the ranges set forth in this footnote (2) to this Form 4. Read SEC document |
| December 11, 2023 Filed Dec 13, 2023 21:15 UTC | Cadre Holdings, Inc. CDRE · Entity 4819 | SaleCommon Stock, par value $.0001 per share ("Common Stock") | 7,436 | $32.57 | $242,221.75 |
DisclosureSEC source: 0001104659-23-125711 · tm2332816-1_4seq1.xml · nonDerivative · entry 1 Browers Blaine · CIK 0001874169 · PRESIDENT 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 77,633 F1 · price: The price reported in Column 4 is a weighted average price. These shares of Common Stock were sold in multiple transactions at prices ranging from $32.50- $32.72. The Reporting Person undertakes to provide to Cadre Holdings, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares of Common Stock sold at each separate price within the ranges set forth in this footnote (1) to this Form 4. Read SEC document |
| August 16, 2023 Filed Aug 17, 2023 22:05 UTC | Cadre Holdings, Inc. CDRE · Entity 4819 | SaleCommon Stock, par value $.0001 per share ("Common Stock") | 3,758 | $25.01 | $93,992.09 |
DisclosureSEC source: 0001104659-23-093143 · tm2323997-2_4seq1.xml · nonDerivative · entry 1 Browers Blaine · CIK 0001874169 · PRESIDENT 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 85,069 F1 · price: The price reported in Column 4 is a weighted average price. These shares of Common Stock were sold in multiple transactions at prices ranging from $25.00- $25.08. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares of Common Stock sold at each separate price within the ranges set forth in this footnote (1) to this Form 4. Read SEC document |
| March 18, 2023 Filed Mar 21, 2023 20:31 UTC | Cadre Holdings, Inc. CDRE · Entity 4819 | Exercise / conversionPhantom Stock · Derivative | 55,333 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-035093 · tm2310038d4_4.xml · derivative · entry 3 Browers Blaine · CIK 0001874169 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 55,333 Underlying: Common Stock · 55,333 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: On March 9, 2022, the Reporting Person was granted a phantom stock award under the Safariland Group Amended and Restated 2021 Phantom Restricted Share Plan consisting of 166,000 shares of phantom stock. Each share of phantom stock is the economic equivalent of one share of Common Stock. 55,334 shares of phantom stock vested and became non-forfeitable on March 18, 2022, 55,333 shares of phantom stock vest and become non-forfeitable on March 18, 2023, and 55,333 shares of phantom stock will vest and become non-forfeitable on March 18, 2024. F1 · derivative.exercise_date: On March 9, 2022, the Reporting Person was granted a phantom stock award under the Safariland Group Amended and Restated 2021 Phantom Restricted Share Plan consisting of 166,000 shares of phantom stock. Each share of phantom stock is the economic equivalent of one share of Common Stock. 55,334 shares of phantom stock vested and became non-forfeitable on March 18, 2022, 55,333 shares of phantom stock vest and become non-forfeitable on March 18, 2023, and 55,333 shares of phantom stock will vest and become non-forfeitable on March 18, 2024. F1 · derivative.expiration_date: On March 9, 2022, the Reporting Person was granted a phantom stock award under the Safariland Group Amended and Restated 2021 Phantom Restricted Share Plan consisting of 166,000 shares of phantom stock. Each share of phantom stock is the economic equivalent of one share of Common Stock. 55,334 shares of phantom stock vested and became non-forfeitable on March 18, 2022, 55,333 shares of phantom stock vest and become non-forfeitable on March 18, 2023, and 55,333 shares of phantom stock will vest and become non-forfeitable on March 18, 2024. Read SEC document |
| March 18, 2023 Filed Mar 21, 2023 20:31 UTC | Cadre Holdings, Inc. CDRE · Entity 4819 | Tax withholdingCommon Stock | 21,774 | $19.02 | $414,141.48 |
DisclosureSEC source: 0001104659-23-035093 · tm2310038d4_4.xml · nonDerivative · entry 2 Browers Blaine · CIK 0001874169 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 89,286 F2 · shares: Represents the number of shares of Common Stock withheld by the Issuer to satisfy the tax withholding obligations incurred by Mr. Browers as a result of the vesting on March 18, 2023 of a portion of the phantom stock award. Read SEC document |
| March 18, 2023 Filed Mar 21, 2023 20:31 UTC | Cadre Holdings, Inc. CDRE · Entity 4819 | Exercise / conversionCommon stock, par value $.0001 per share ("Common Stock") | 55,333 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-23-035093 · tm2310038d4_4.xml · nonDerivative · entry 1 Browers Blaine · CIK 0001874169 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 111,060 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: On March 9, 2022, the Reporting Person was granted a phantom stock award under the Safariland Group Amended and Restated 2021 Phantom Restricted Share Plan consisting of 166,000 shares of phantom stock. Each share of phantom stock is the economic equivalent of one share of Common Stock. 55,334 shares of phantom stock vested and became non-forfeitable on March 18, 2022, 55,333 shares of phantom stock vest and become non-forfeitable on March 18, 2023, and 55,333 shares of phantom stock will vest and become non-forfeitable on March 18, 2024. Read SEC document |
| March 13, 2023 Filed Mar 15, 2023 20:31 UTC | Cadre Holdings, Inc. CDRE · Entity 4819 | GrantStock Option (right to purchase) · Derivative | 37,215 | $0.00 Strike: $20.53 | $0.00 |
DisclosureSEC source: 0001104659-23-032823 · tm238945-8_4seq1.xml · derivative · entry 2 Browers Blaine · CIK 0001874169 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,215 Underlying: Common Stock · 37,215 shares Expires 2033-03-13 F2 · derivative.exercise_date: The option to purchase shares of the Issuer's Common Stock was granted under the Plan. Options to purchase 12,405 shares of the Issuer's Common Stock will vest and become exercisable on each of March 13, 2024, March 13, 2025 and March 13, 2026. Read SEC document |
| March 13, 2023 Filed Mar 15, 2023 20:31 UTC | Cadre Holdings, Inc. CDRE · Entity 4819 | GrantRestricted Stock Units · Derivative | 10,177 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-032823 · tm238945-8_4seq1.xml · derivative · entry 1 Browers Blaine · CIK 0001874169 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,177 Underlying: Common Stock · 10,177 shares Expires not disclosed F1 · derivative.exercise_price: Comprised of a restricted stock units award granted under the Issuer's 2021 Stock Incentive Plan (the "Plan") consisting of 10,177 shares of the Issuer's common stock, par value $0.0001 per share ("Common Stock"). 3,391 shares of the Issuer's Common Stock will vest and become non-forfeitable on March 13, 2024 and 3,393 shares of the Issuer's Common Stock will vest and become non-forfeitable on each of March 13, 2025 and March 13, 2026. F1 · derivative.exercise_date: Comprised of a restricted stock units award granted under the Issuer's 2021 Stock Incentive Plan (the "Plan") consisting of 10,177 shares of the Issuer's common stock, par value $0.0001 per share ("Common Stock"). 3,391 shares of the Issuer's Common Stock will vest and become non-forfeitable on March 13, 2024 and 3,393 shares of the Issuer's Common Stock will vest and become non-forfeitable on each of March 13, 2025 and March 13, 2026. F1 · derivative.expiration_date: Comprised of a restricted stock units award granted under the Issuer's 2021 Stock Incentive Plan (the "Plan") consisting of 10,177 shares of the Issuer's common stock, par value $0.0001 per share ("Common Stock"). 3,391 shares of the Issuer's Common Stock will vest and become non-forfeitable on March 13, 2024 and 3,393 shares of the Issuer's Common Stock will vest and become non-forfeitable on each of March 13, 2025 and March 13, 2026. Read SEC document |
| March 09, 2023 Filed Mar 13, 2023 20:15 UTC | Cadre Holdings, Inc. CDRE · Entity 4819 | Exercise / conversionCommon Stock · Derivative | 2,919 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-031775 · tm238945-1_4seq1.xml · derivative · entry 3 Browers Blaine · CIK 0001874169 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,836 Underlying: Common Stock · 2,919 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Comprised of a restricted stock award previously granted on March 9, 2022 under the Issuer's 2021 Stock Incentive Plan (the "Restricted Stock Award") consisting of 8,755 restricted shares of Common Stock. 2,919 restricted shares of Common Stock vested and became non-forfeitable on March 9, 2023 and 2,918 restricted shares of Common Stock will vest and become non-forfeitable on each of March 9, 2024 and March 9, 2025. F1 · derivative.exercise_date: Comprised of a restricted stock award previously granted on March 9, 2022 under the Issuer's 2021 Stock Incentive Plan (the "Restricted Stock Award") consisting of 8,755 restricted shares of Common Stock. 2,919 restricted shares of Common Stock vested and became non-forfeitable on March 9, 2023 and 2,918 restricted shares of Common Stock will vest and become non-forfeitable on each of March 9, 2024 and March 9, 2025. F1 · derivative.expiration_date: Comprised of a restricted stock award previously granted on March 9, 2022 under the Issuer's 2021 Stock Incentive Plan (the "Restricted Stock Award") consisting of 8,755 restricted shares of Common Stock. 2,919 restricted shares of Common Stock vested and became non-forfeitable on March 9, 2023 and 2,918 restricted shares of Common Stock will vest and become non-forfeitable on each of March 9, 2024 and March 9, 2025. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.